The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.
Chemoprevention
impactzone
CSN Member Posts: 558 Member
At my oncologist meeting we had a long discussion about this company and their approach to cancer recurrence issues;
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2562024
http://www.genomeweb.com/biotechtransferweek/ua-uc-irvine-researchers-form-company-further-develop-colon-cancer-chemopreventi?page=show
(this one you must register to read the article)
What is the amazing stat is the 95% over 3 year reduction in recurrence with no side effects of polyps only. While colonoscopies do a great job of getting polyps, perhaps this study leads to possibilities of use in trials. There was some discussion about developing clinical trials for individuals to possibly delay recurrences in metastatic disease. Essentially this comes out of the old issue of aspirin and colon cancer ( large dosages seem to make a difference but it must be for a long time and at high dosages that create other problems) and then looking at the addition of two new drugs ( difluoromethylornithine (DFMO) and sulindac ) that have been used extensively for other purposes. I often post medical studies and do not leave much discussion as (1) I hate typing a lot and (2) you have to be very precise in what you say. My degree is in biochem from UCSB and I teach science so I have a background in the sciences and realize that the last 3 posts (Australian science, PARC and chemoprevention) do not have benefits that today someone can get but they provide a pathway and a feeling of hope. I love researchers who try these out and am interested when oncs know about these studies.
Chip
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2562024
http://www.genomeweb.com/biotechtransferweek/ua-uc-irvine-researchers-form-company-further-develop-colon-cancer-chemopreventi?page=show
(this one you must register to read the article)
What is the amazing stat is the 95% over 3 year reduction in recurrence with no side effects of polyps only. While colonoscopies do a great job of getting polyps, perhaps this study leads to possibilities of use in trials. There was some discussion about developing clinical trials for individuals to possibly delay recurrences in metastatic disease. Essentially this comes out of the old issue of aspirin and colon cancer ( large dosages seem to make a difference but it must be for a long time and at high dosages that create other problems) and then looking at the addition of two new drugs ( difluoromethylornithine (DFMO) and sulindac ) that have been used extensively for other purposes. I often post medical studies and do not leave much discussion as (1) I hate typing a lot and (2) you have to be very precise in what you say. My degree is in biochem from UCSB and I teach science so I have a background in the sciences and realize that the last 3 posts (Australian science, PARC and chemoprevention) do not have benefits that today someone can get but they provide a pathway and a feeling of hope. I love researchers who try these out and am interested when oncs know about these studies.
Chip
Discussion Boards
- All Discussion Boards
- 7 Cancer Survivors Network Information
- 6 Welcome to CSN
- 1 CSN Update
- 122.7K Cancer specific
- 2.8K Anal Cancer
- 457 Bladder Cancer
- 311 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 410 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 682 Leukemia
- 805 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 243 Multiple Myeloma
- 7.2K Ovarian Cancer
- 71 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.7K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 745 Skin Cancer
- 663 Stomach Cancer
- 194 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.5K Lifestyle Discussion Boards